PI3K/Akt/mTOR pathway dual inhibitor BEZ235 suppresses the stemness of colon cancer stem cells.
about
Anti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical AppraisalRenal Cancer Stem Cells: Characterization and Targeted TherapiesThe identification and validation of Trichosstatin A as a potential inhibitor of colon tumorigenesis and colon cancer stem-like cellsDehydroglyasperin D Inhibits the Proliferation of HT-29 Human Colorectal Cancer Cells Through Direct Interaction With Phosphatidylinositol 3-kinase.Resistance to Cell Death and Its Modulation in Cancer Stem Cells.Therapeutic Potential of Targeting PI3K/AKT Pathway in Treatment of Colorectal Cancer: Rational and Progress.Approaches for targeting cancer stem cells drug resistance.Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia-inducible factors HIF1α and HIF2α.Targeted inhibition of the phosphoinositide 3-kinase impairs cell proliferation, survival, and invasion in colon cancerDysregulated lncRNA-UCA1 contributes to the progression of gastric cancer through regulation of the PI3K-Akt-mTOR signaling pathway.RAPTOR up-regulation contributes to resistance of renal cancer cells to PI3K-mTOR inhibition.Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK-JNK-mediated AKT/mTOR signaling pathway.Increased PD-L1 expression in breast and colon cancer stem cells.Novel strategies for molecular targeting to cancer.Physiological Hypoxia Enhances Stemness Preservation, Proliferation, and Bidifferentiation of Induced Hepatic Stem Cells.Study on Biological Characteristics and Mechanism of Paclitaxel Induced Drug Resistance in Endometrial Carcinoma Cells
P2860
Q26744536-2242F83B-104D-4208-9035-060A2F0F8754Q26746970-20BEF4B1-B323-4723-B304-D2FD6D097EB5Q33733048-B1EFB5CE-268D-4A99-B2A6-37BBA754057FQ36762097-247323DB-39BE-4978-8668-792099E63451Q37708637-645B959F-78D8-4F84-9AB4-037DDC90FC02Q38946538-E3B5AD8A-42CD-44EE-BF6F-BF1453F410B0Q38971795-6E8BE29B-1970-42B0-A514-6C06BDCA6960Q38997399-E2B2F110-F044-459E-AA02-3F544AF7210FQ42360077-E91F294E-EFF8-4620-A211-4D9408702528Q47139829-D86DA1B2-E20B-4523-AEB3-85FC062DECE3Q48123819-6016302C-2122-4CFB-A4AC-B4990760FC96Q49981787-4D3FCD4A-12EF-4BBD-B683-808EE38D4500Q51178295-E9AAA13E-EF7E-433D-BA76-368B3643C80AQ53171440-3990B992-F667-4078-B89B-50BAC1B23D71Q53412714-99C1B0E5-AAD8-424E-9EFA-2CD870230781Q58800089-40ADA7C7-D965-4126-901B-269178433B2E
P2860
PI3K/Akt/mTOR pathway dual inhibitor BEZ235 suppresses the stemness of colon cancer stem cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
PI3K/Akt/mTOR pathway dual inh ...... ss of colon cancer stem cells.
@en
type
label
PI3K/Akt/mTOR pathway dual inh ...... ss of colon cancer stem cells.
@en
prefLabel
PI3K/Akt/mTOR pathway dual inh ...... ss of colon cancer stem cells.
@en
P2093
P2860
P356
P1476
PI3K/Akt/mTOR pathway dual inh ...... ess of colon cancer stem cells
@en
P2093
Jun-Ping Liu
Michael Monteiro
Renfu Shao
P2860
P304
P356
10.1111/1440-1681.12493
P577
2015-12-01T00:00:00Z